Adherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.
James Davis, PhD
Advertisement
Articles by James Davis, PhD
Advertisement
Latest Updated Articles
- Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic Therapy
Published: September 23rd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
5
